---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-023728"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:11:26.489853+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Qualigen shareholders approve all proposals; name change to AIxCrypto, Faraday Future becomes majority holder

## Summary
- Stockholders approved private placement of 337,432 common shares and 39,943 Series B convertible preferred shares.
- Faraday Future becomes majority owner with ~55% direct equity (incl. affiliates ~63%); will nominate majority of board.
- Company rebrands to AIxCrypto Holdings, Inc., ticker changes to AIXC on Nov 20, 2025 from QLGN.
- Company transitions from biotech to AI × Web3 platform, unveiling three-year roadmap at Nasdaq ceremony on Nov 20.

## SEC filing metadata
- accession: 0001493152-25-023728
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000149315225023728/0001493152-25-023728-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000149315225023728/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-023728
- JSON: https://secwatch.observer/filing/0001493152-25-023728.json
- Plain text: https://secwatch.observer/filing/0001493152-25-023728.txt

## Key facts
- Governance Changes
  AIxCrypto Holdings, Inc.: Changed corporate name from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc (effective 2025-11-14).
  - Change: charter amendment
  - Effective: 2025-11-14
  source text: On November 14, 2025, Qualigen Therapeutics, Inc. (the “Company”) filed with the State of Delaware a Certificate of Amendment to our Amended and Restated Certificate of Incorporation to change our corporate name from “Qualigen Therapeutics, Inc.” to “AIxCrypto Holdings, Inc.”
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460702/000149315225023728/0001493152-25-023728-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.